Related Experiment Video
Updated: Mar 27, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Computational framework for therapeutic target discovery via perturbation simulation: application to cystic fibrosis
George Sun1, Yi-Hui Zhou1,2
1High Dimensional Predictive Biological Lab is located at 1 Lampe Drive, North Carolina State University, Raleigh, NC, 27695, United States.
Abstract:
Computational methods for therapeutic target discovery face challenges in integrating multi-scale biological data and predicting system-wide therapeutic effects. We present a computational framework that integrates single-cell transcriptomics, weighted gene co-expression network analysis (WGCNA), and computational perturbation simulation to systematically discover novel therapeutic targets. The framework constructs a knowledge graph comprising 29 896 nodes (23 530 genes and 6366 pathways) with 322 136 edges, integrating gene-gene, gene-pathway, and module relationships. Using perturbation simulation algorithms, we systematically explored 265 candidate targets, scoring each based on perturbation magnitude, module response, therapeutic effect, and statistical significance. Applied to single-cell RNA sequencing data from 38 patients (51 415 cells), the framework identified 66 novel therapeutic targets, including nine very high novelty targets. Computational validation demonstrates efficient scalability (knowledge graph construction: <5 min; 265 perturbation simulations: <2 min) and robust performance across different module sizes. This approach represents a novel computational method for systems-level therapeutic target discovery, with generalizable applications to other complex diseases.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Pharmacogenomics: Identification of New Drug Targets

